Literature DB >> 24471864

Multiple sclerosis in children and adolescents: incidence and clinical picture - new insights from the nationwide German surveillance (2009-2011).

K Reinhardt1, S Weiss, J Rosenbauer, J Gärtner, R von Kries.   

Abstract

BACKGROUND AND
PURPOSE: Pediatric multiple sclerosis (MS) clinical and incidence data have been reported for several countries but valid age dependent incidence data are not yet available. The true incidence of pediatric MS in Germany was estimated and the clinical characteristics at diagnosis according to the 2005 McDonald criteria are described.
METHODS: Between 2009 and 2011 active prospective nationwide surveillance for MS in children and adolescents ≤15 years included all pediatric hospitals, MS centers and private practices specialized in MS. Data were adjusted for under-reporting by capture-recapture from an independent second source.
RESULTS: The estimated incidence of pediatric MS was 0.64 per 100,000 person-years with clear increase from age group ≤10 (0.09/100,000) to 2.64 per 100,000 in age group 14-15 years. All had relapsing-remitting disease with polysymptomatic onset in half of the cases. Spinal MRI with positive findings in two-thirds of patients contributed to diagnosis.
CONCLUSION: Using an active prospective surveillance system and the McDonald criteria for first MS diagnosis the age-related incidence of pediatric MS in Germany was uncovered and is more common than in previous estimates. Thorough application of McDonald criteria and inclusion of spinal MRI data allowed for early diagnosis in almost 90% of cases.
© 2014 The Author(s) European Journal of Neurology © 2014 EFNS.

Entities:  

Keywords:  ESPED; Germany; capture−recapture method; children and adolescents; epidemiology; incidence; multiple sclerosis; surveillance

Mesh:

Year:  2014        PMID: 24471864     DOI: 10.1111/ene.12371

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  20 in total

1.  Characteristics of Children and Adolescents With Multiple Sclerosis.

Authors:  Anita L Belman; Lauren B Krupp; Cody S Olsen; John W Rose; Greg Aaen; Leslie Benson; Tanuja Chitnis; Mark Gorman; Jennifer Graves; Yolander Harris; Tim Lotze; Jayne Ness; Moses Rodriguez; Jan-Mendelt Tillema; Emmanuelle Waubant; Bianca Weinstock-Guttman; T Charles Casper
Journal:  Pediatrics       Date:  2016-07       Impact factor: 7.124

Review 2.  Multiple sclerosis in children: an update on clinical diagnosis, therapeutic strategies, and research.

Authors:  Amy Waldman; Angelo Ghezzi; Amit Bar-Or; Yann Mikaeloff; Marc Tardieu; Brenda Banwell
Journal:  Lancet Neurol       Date:  2014-09       Impact factor: 44.182

Review 3.  [Multiple sclerosis in childhood and adolescence : Complex, chronic and differentiated].

Authors:  A Blaschek; P Huppke; T Kümpfel; W Müller-Felber; K Rostasy
Journal:  Nervenarzt       Date:  2017-12       Impact factor: 1.214

4.  Evaluation of Delta-Aminolevulinic Dehydratase Activity, Oxidative Stress Biomarkers, and Vitamin D Levels in Patients with Multiple Sclerosis.

Authors:  Carla Roberta Nunes Polachini; Roselia Maria Spanevello; Daniela Zanini; Jucimara Baldissarelli; Luciane Belmonte Pereira; Maria Rosa Chitolina Schetinger; Ivana Beatrice Mânica da Cruz; Charles Elias Assmann; Margarete Dulce Bagatini; Vera Maria Morsch
Journal:  Neurotox Res       Date:  2015-12-21       Impact factor: 3.911

Review 5.  Biological determinants impact the neurovascular toxicity of nicotine and tobacco smoke: A pharmacokinetic and pharmacodynamics perspective.

Authors:  Sabrina Rahman Archie; Sejal Sharma; Elizabeth Burks; Thomas Abbruscato
Journal:  Neurotoxicology       Date:  2022-02-09       Impact factor: 4.294

Review 6.  Therapeutic Approach to the Management of Pediatric Demyelinating Disease: Multiple Sclerosis and Acute Disseminated Encephalomyelitis.

Authors:  J Nicholas Brenton; Brenda L Banwell
Journal:  Neurotherapeutics       Date:  2016-01       Impact factor: 7.620

Review 7.  Pediatric Multiple Sclerosis: an Update.

Authors:  Scott Otallah; Brenda Banwell
Journal:  Curr Neurol Neurosci Rep       Date:  2018-09-18       Impact factor: 5.081

8.  Predictors of Multiple Sclerosis Severity Score in Patients with Multiple Sclerosis.

Authors:  Ahmed N Albatineh; Raed Alroughani; Rabeah Al-Temaimi
Journal:  Int J MS Care       Date:  2020-01-13

9.  The global prevalence of familial multiple sclerosis: an updated systematic review and meta-analysis.

Authors:  Naeim Ehtesham; Maryam Zare Rafie; Meysam Mosallaei
Journal:  BMC Neurol       Date:  2021-06-28       Impact factor: 2.474

Review 10.  Use of Disease-Modifying Therapies in Pediatric MS.

Authors:  Marta Simone; Tanuja Chitnis
Journal:  Curr Treat Options Neurol       Date:  2016-08       Impact factor: 3.972

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.